Matrik Biotek Shikari® (Q-ATDAR) ELISA has been especially developed for the qualitative analysis of antibodies to Daratumumab (Darzalex®) in serum and plasma samples.
|Required Volume (µl)||10|
|Total Time (min)||140|
|Detection Limit (ng/mL)||-|
|Spike Recovery (%)||-|
|Shelf Life (year)||1|
Please note that the documentation provided is for reference use only. For the most updated version, please contact us.
For Research Use Only
Manufactured by Matriks Biotek Co.
Questions about this product? Ready to place an order? Email us at email@example.com or give us a call: (650) 486-1541